Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants
Top Cited Papers
- 3 April 2003
- Vol. 21 (23), 3265-3272
- https://doi.org/10.1016/s0264-410x(03)00230-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infantsThe Pediatric Infectious Disease Journal, 2002
- Assessing Efficacy ofHaemophilus influenzaeType b Combination VaccinesClinical Infectious Diseases, 2001
- Bridging Phase 2 and Phase 3 Pneumococcal Immunologic Data for Future Combination VaccinesClinical Infectious Diseases, 2001
- Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlersThe Pediatric Infectious Disease Journal, 2001
- Serological Basis for Use of Meningococcal Serogroup C Conjugate Vaccines in the United Kingdom: Reevaluation of Correlates of ProtectionInfection and Immunity, 2001
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part IClinical Infectious Diseases, 2000
- Immunogenicity and Impact on Nasopharyngeal Carriage of a Nonavalent Pneumococcal Conjugate VaccineThe Journal of Infectious Diseases, 1999
- Safety, Immunogenicity, and Efficacy in Infancy of Oligosaccharide Conjugate Haemophilus influenzae Type b Vaccine in a United States Population: Possible Implications for Optimal UseThe Journal of Infectious Diseases, 1992
- The Efficacy in Navajo Infants of a Conjugate Vaccine Consisting ofHaemophilus influenzaeType b Polysaccharide andNeisseria meningitidisOuter-Membrane Protein ComplexNew England Journal of Medicine, 1991